158 related articles for article (PubMed ID: 29956728)
1. Detection of dysregulated competing endogenous RNA modules associated with clear cell kidney carcinoma.
Wang H; Xu D; Huang H; Cui Y; Li C; Zhang C; Guo S; Zhang L; Xu X; Xu J; Lu J; Wang L; Li K
Mol Med Rep; 2018 Aug; 18(2):1963-1972. PubMed ID: 29956728
[TBL] [Abstract][Full Text] [Related]
2. Identification and Validation of Two Novel Prognostic lncRNAs in Kidney Renal Clear Cell Carcinoma.
Song J; Peng J; Zhu C; Bai G; Liu Y; Zhu J; Liu J
Cell Physiol Biochem; 2018; 48(6):2549-2562. PubMed ID: 30121668
[TBL] [Abstract][Full Text] [Related]
3. Identification of module biomarkers from the dysregulated ceRNA-ceRNA interaction network in lung adenocarcinoma.
Shao T; Wu A; Chen J; Chen H; Lu J; Bai J; Li Y; Xu J; Li X
Mol Biosyst; 2015 Nov; 11(11):3048-58. PubMed ID: 26325208
[TBL] [Abstract][Full Text] [Related]
4. LINC00997, a novel long noncoding RNA, contributes to metastasis via regulation of S100A11 in kidney renal clear cell carcinoma.
Chang Y; Li N; Yuan W; Wang G; Wen J
Int J Biochem Cell Biol; 2019 Nov; 116():105590. PubMed ID: 31442606
[TBL] [Abstract][Full Text] [Related]
5. Immune associated LncRNAs identify novel prognostic subtypes of renal clear cell carcinoma.
Khadirnaikar S; Kumar P; Pandi SN; Malik R; Dhanasekaran SM; Shukla SK
Mol Carcinog; 2019 Apr; 58(4):544-553. PubMed ID: 30520148
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA MRCCAT1 promotes metastasis of clear cell renal cell carcinoma via inhibiting NPR3 and activating p38-MAPK signaling.
Li JK; Chen C; Liu JY; Shi JZ; Liu SP; Liu B; Wu DS; Fang ZY; Bao Y; Jiang MM; Yuan JH; Qu L; Wang LH
Mol Cancer; 2017 Jun; 16(1):111. PubMed ID: 28659173
[TBL] [Abstract][Full Text] [Related]
7. Construction and analysis of dysregulated lncRNA-associated ceRNA network identified novel lncRNA biomarkers for early diagnosis of human pancreatic cancer.
Zhou M; Diao Z; Yue X; Chen Y; Zhao H; Cheng L; Sun J
Oncotarget; 2016 Aug; 7(35):56383-56394. PubMed ID: 27487139
[TBL] [Abstract][Full Text] [Related]
8. Prognostic signatures for renal cancer as identified by long non-coding and miRNA competing endogenous network analysis.
Gao H; Chen X; Shang Z; Niu Y
Oncol Rep; 2018 Aug; 40(2):959-967. PubMed ID: 29901101
[TBL] [Abstract][Full Text] [Related]
9. The gain and loss of long noncoding RNA associated-competing endogenous RNAs in prostate cancer.
Liu D; Yu X; Wang S; Dai E; Jiang L; Wang J; Yang Q; Yang F; Zhou S; Jiang W
Oncotarget; 2016 Aug; 7(35):57228-57238. PubMed ID: 27528026
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of LINC00160 predicts poor outcome and promotes progression of clear cell renal cell carcinoma.
Cheng G; Yu Y; Wang L; Pan Q
Aging (Albany NY); 2020 Apr; 12(8):7448-7464. PubMed ID: 32315986
[TBL] [Abstract][Full Text] [Related]
11. Competing endogenous RNA networks and gastric cancer.
Guo LL; Song CH; Wang P; Dai LP; Zhang JY; Wang KJ
World J Gastroenterol; 2015 Nov; 21(41):11680-7. PubMed ID: 26556995
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of enhancer RNA EMX2OS is associated with poor prognosis in kidney renal clear cell carcinoma.
Jiang H; Chen H; Wan P; Song S; Chen N
Aging (Albany NY); 2020 Nov; 12(24):25865-25877. PubMed ID: 33234727
[TBL] [Abstract][Full Text] [Related]
13. Identification of the key genes and pathways involved in the tumorigenesis and prognosis of kidney renal clear cell carcinoma.
Cui H; Shan H; Miao MZ; Jiang Z; Meng Y; Chen R; Zhang L; Liu Y
Sci Rep; 2020 Mar; 10(1):4271. PubMed ID: 32144299
[TBL] [Abstract][Full Text] [Related]
14. Identification and functional characterization of lncRNAs acting as ceRNA involved in the malignant progression of glioblastoma multiforme.
Zhang K; Li Q; Kang X; Wang Y; Wang S
Oncol Rep; 2016 Nov; 36(5):2911-2925. PubMed ID: 27600337
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive characterization of lncRNA-mRNA related ceRNA network across 12 major cancers.
Zhang Y; Xu Y; Feng L; Li F; Sun Z; Wu T; Shi X; Li J; Li X
Oncotarget; 2016 Sep; 7(39):64148-64167. PubMed ID: 27580177
[TBL] [Abstract][Full Text] [Related]
16. Expression pattern of long non-coding RNAs in renal cell carcinoma revealed by microarray.
Qin C; Han Z; Qian J; Bao M; Li P; Ju X; Zhang S; Zhang L; Li S; Cao Q; Lu Q; Li J; Shao P; Meng X; Zhang W; Yin C
PLoS One; 2014; 9(6):e99372. PubMed ID: 24905231
[TBL] [Abstract][Full Text] [Related]
17. The promising novel biomarkers and candidate small molecule drugs in kidney renal clear cell carcinoma: Evidence from bioinformatics analysis of high-throughput data.
Zhang B; Wu Q; Wang Z; Xu R; Hu X; Sun Y; Wang Q; Ju F; Ren S; Zhang C; Qin L; Ma Q; Zhou YL
Mol Genet Genomic Med; 2019 May; 7(5):e607. PubMed ID: 30793530
[TBL] [Abstract][Full Text] [Related]
18. Identifying survival-associated ceRNA clusters in cholangiocarcinoma.
Wan M; Zhang FM; Li ZL; Kang PC; Jiang PM; Wang YM; Wang ZD; Zhong XY; Li CL; Wang H; Zhao SY; Cui YF
Oncol Rep; 2016 Sep; 36(3):1542-50. PubMed ID: 27432084
[TBL] [Abstract][Full Text] [Related]
19. Construction of a long non‑coding RNA-mediated competitive endogenous RNA network reveals global patterns and regulatory markers in gestational diabetes.
Leng L; Zhang C; Ren L; Li Q
Int J Mol Med; 2019 Feb; 43(2):927-935. PubMed ID: 30569156
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive characterization of immune- and inflammation-associated biomarkers based on multi-omics integration in kidney renal clear cell carcinoma.
Zhao E; Li L; Zhang W; Wang W; Chan Y; You B; Li X
J Transl Med; 2019 May; 17(1):177. PubMed ID: 31133033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
